HTLV-1 Tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration

The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein repressed the transcriptional activity of wild-type p53 through its N-terminal trans-activation domain. Although Tax did not directly bind to p53, this repression required the activation of CREB pathway by Tax. In contrast to a recent report by Pise-Masison et al. (1998a,b) we found that the phosphorylation of p53 on Ser 15 is not a major cause of the Tax-mediated inactivation of p53. However, Tax with a mutation in the coactivator CBP-binding site (K88A), which activates NF-κB but not the CREB pathway, could not repress the p53 trans-activation function. Moreover, Tax inhibited p53 binding to CBP in vitro and inhibited synergistic activation of transcription by CBP and p53. Thus, Tax is likely to compete with p53 in binding with CBP, thereby repressing its trans-activation function.

[1]  A. Berk,et al.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein , 1992, Nature.

[2]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[3]  J. Pipas,et al.  Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[5]  A. Jochemsen,et al.  Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins , 1999, Molecular and Cellular Biology.

[6]  M. Yoshida,et al.  HTLV‐1 Tax protein interacts with cyclin‐dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. , 1996, The EMBO journal.

[7]  W. Kaelin,et al.  Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73 , 1998, Molecular and Cellular Biology.

[8]  A. Levine,et al.  mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein , 1996, Molecular and cellular biology.

[9]  Kuan-Teh Jeang,et al.  Human T Cell Leukemia Virus Type 1 Oncoprotein Tax Targets the Human Mitotic Checkpoint Protein MAD1 , 1998, Cell.

[10]  S. Yamaoka,et al.  Constitutive activation of NF‐kappa B is essential for transformation of rat fibroblasts by the human T‐cell leukemia virus type I Tax protein. , 1996, The EMBO journal.

[11]  Takeshi Suzuki,et al.  Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site , 1999, Oncogene.

[12]  S. Ishii,et al.  Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin , 1994, Journal of virology.

[13]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[14]  P. Friedman,et al.  Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.

[15]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[16]  N. Shiama.  The p300/CBP family: integrating signals with transcription factors and chromatin. , 1997, Trends in cell biology.

[17]  H. Giebler,et al.  Binding of p53 to the KIX Domain of CREB Binding Protein , 1999, The Journal of Biological Chemistry.

[18]  J. Brady,et al.  Inhibition of p53 Transactivation Function by the Human T-Cell Lymphotropic Virus Type 1 Tax Protein , 1998, Journal of Virology.

[19]  K. Shimotohno,et al.  Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes , 1997, Oncogene.

[20]  W. Greene,et al.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. , 1990, Genes & development.

[21]  J. Roth,et al.  Inactivation of p53 but Not p73 by Adenovirus Type 5 E1B 55-Kilodalton and E4 34-Kilodalton Oncoproteins , 1998, Journal of Virology.

[22]  Y. Sung,et al.  Transactivation Ability of p53 Transcriptional Activation Domain Is Directly Related to the Binding Affinity to TATA-binding Protein (*) , 1995, The Journal of Biological Chemistry.

[23]  N. Yamamoto,et al.  Molecular cloning of cDNA encoding gp68 of adult T-cell leukaemia-associated antigen: evidence for expression of the pX IV region of human T-cell leukaemia virus. , 1985, The Journal of general virology.

[24]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[25]  K. Jeang,et al.  Human T-Cell Leukemia Virus Type 1 Tax and Cell Cycle Progression: Role of Cyclin D-cdk and p110Rb , 1998, Molecular and Cellular Biology.

[26]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[27]  M. Yoshida,et al.  Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. , 1999, Virology.

[28]  Y. Nakatani,et al.  An Exposed KID-Like Domain in Human T-Cell Lymphotropic Virus Type 1 Tax Is Responsible for the Recruitment of Coactivators CBP/p300 , 1998, Molecular and Cellular Biology.

[29]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[30]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[31]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[32]  S. J. Marriott,et al.  Disruption of Nucleotide Excision Repair by the Human T-Cell Leukemia Virus Type 1 Tax Protein , 1999, Journal of Virology.

[33]  N. Tsuchida,et al.  Aberrant Expression of the p53 Tumor Suppressor Gene in Adult T‐Cell Leukemia and HTLV‐I‐infected Cells , 1993, Japanese journal of cancer research : Gann.

[34]  N. Tsuchida,et al.  Aberrant expression and function of p53 in T‐cells immortalized by HTLV‐I Tax1 , 1997, FEBS letters.

[35]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[36]  D. Livingston,et al.  Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.

[37]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[38]  Ettore Appella,et al.  Phosphorylation of p53: a Novel Pathway for p53 Inactivation in Human T-Cell Lymphotropic Virus Type 1-Transformed Cells , 1998, Journal of Virology.

[39]  J. Nyborg,et al.  Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control , 1999, Oncogene.

[40]  T. Uchiyama.  Human T cell leukemia virus type I (HTLV-I) and human diseases. , 1997, Annual review of immunology.

[41]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[42]  A. Cereseto,et al.  Human T-Cell Lymphotropic/Leukemia Virus Type 1 Tax Abrogates p53-Induced Cell Cycle Arrest and Apoptosis through Its CREB/ATF Functional Domain , 1998, Journal of Virology.

[43]  K. Hayashi,et al.  Genetic Alteration of p53 in Some Patients with Adult T‐Cell Leukemia , 1991, Japanese journal of cancer research : Gann.

[44]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[45]  N. Horikoshi,et al.  Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor , 1996, Science.

[46]  F. Diella,et al.  p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. , 1996, Blood.

[47]  E. Conseiller,et al.  Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains , 1999, Oncogene.

[48]  W. Kaelin,et al.  p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.

[49]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[50]  H. Shih,et al.  Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP , 1996, Nature.

[51]  Chikashi Ishioka,et al.  Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.